|
Thursday 23rd of March 2006:
|
|
19h |
Hypertension Symposium |
|
|
Friday 24th of March 2006:
|
|
12h0014h00: |
Registration |
|
|
14h0014h15: |
Opening Remarks |
|
|
14h1514h45: |
50 ans de Progrès dans les Maladies Génétique Rénales |
J. P Grunfeld |
|
14h4515h15: |
Combined
Liver Kidney Transplantation in Children |
P. Cochat |
|
15h1515h45: |
Delayed Graft Function |
G. Mourad |
|
15h4516h00: |
Discussion |
|
|
16h0016h20: |
Coffee Break |
|
|
16h2016h50: |
The Changing Epidemiology of A.R.F |
N. Lameire |
|
16h5017h20 |
Organisation du Dépistage des Maladies Rénales et de
L’Insuffisance Rénale |
J. P Grunfeld |
|
17h2017h50: |
From
Clinical Trials to Practices Approaches to Chronic Kidney
Diseases in Developing Countries |
G. Remuzzi |
|
18h30 |
Opening Ceremony |
|
|
Saturday 25th
March 2006: |
|
9h009h30:
|
The Optimal
Treatment for the High Risk patient |
B. Canaud |
|
9h3010h00:
|
What can
modern H.DTechnology do for the patient? |
J.P
Deetjen |
|
10h0010h30:
|
Subclinical
Inflammation and the Peritoneal Membrane
|
A. Joerres |
|
10h3010h45:
|
Discussion
|
|
|
10h4511h05:
|
Coffee Break
|
|
|
11h0511h35:
|
Why is OLHDF
the best Therapy Option? |
B. Canaud |
|
11h3512h05:
|
Light at the
end of the tunnel: Do new PD solutions |
|
| |
have a
Clinical Impact ? |
A. Joerres |
|
12h0512h35:
|
The role of
PD as a Renal Replacement Therapy |
N. Lameire |
|
13h0014h00:
|
Lunch
Symposium: DCOR Trial |
W. Suki |
|
14h0014h30:
|
Is Regression
of Chronic Nephropathy Achievable? |
G. Remuzzi |
|
14h3015h00:
|
Rationale of
Immunosuppression Strategies |
R. Barsoum |
|
15h0015h30:
|
Maintenance
Immunosuppression. Which Protocol? |
G. Mourad |
|
15h3015h45:
|
Discussion
|
|
|
15h4516h05:
|
Coffee Break
|
|
| |
Pathology of
Antibody Mediated Rejection
in Renal
Transplantation |
H.K.Kassouf |
|
16h3517h05:
|
Recurrent
Post Transplant Renal Disease |
P. Cochat |
|
17.3518.35:
|
Transplantation Symposium |
|
|
Sunday 26th
of March 2006 : |
|
9h209h30:
|
Inhibition of
Renin Angiotensin system: Effect |
|
| |
in Bilateral
Renal Artery Stenosis |
N.Fares |
|
9h3010h00:
|
The World
Wide Epidemiology of Diabetic Nephropathy |
N.Lameire |
|
10h0010h30:
|
Pathogenesis
of Diabetic Nephropathy |
F.Ziyadeh |
|
10h3011h00:
|
Spectrum of
HCV infection in Clinical Nephropathy |
R.Barsoum |
|
11h0011h15:
|
Discussion
|
|
|
11h1511h35:
|
Coffee Break
|
|
|
11h3512h05:
|
Cardiovascular Risk in Renal Diseases: |
|
| |
Epidemiology
and Mechanisms |
E. Ritz |
|
12h0512h15:
|
Hypertension
and Adequacy of Blood Pressure |
|
| |
Control in
Hemodialysis Patients |
N. Akash |
|
12h1512h45:
|
Salta
Neglected Culprit in the Genesis of Hypertension
|
|
| |
and
Progression of Renal Diseases |
E. Ritz |
|
12h4513h00:
|
Closing
remarks |
|
|
13h00
|
Lunch
|
|
